The study, sponsored by Federico II University, investigates the effects of a polyphenol-rich beverage derived from red grape pomace on non-alcoholic fatty liver disease (NAFLD) and related metabolic conditions in patients with type 2 diabetes. Given the rising prevalence of NAFLD and the absence of pharmacological treatments, this asset addresses a significant unmet medical need. The potential for dietary polyphenols to improve liver health and metabolic profiles could position this beverage favorably in the dietary supplement market, particularly among diabetic and obese populations. The competitive landscape includes other dietary interventions and emerging pharmacotherapies for NAFLD, necessitating a thorough market analysis and strategic positioning. Diligence should focus on regulatory pathways, especially concerning health claims and market entry strategies.